Literature DB >> 24149828

The Clinical COPD Questionnaire: response to pulmonary rehabilitation and minimal clinically important difference.

Samantha S C Kon1, Deniz Dilaver2, Manvi Mittal1, Claire M Nolan3, Amy L Clark2, Jane L Canavan1, Sarah E Jones1, Michael I Polkey1, William D-C Man3.   

Abstract

BACKGROUND: The Clinical COPD Questionnaire (CCQ) is a simple 10-item, health-related quality of life questionnaire (HRQoL) with good psychometric properties. However, little data exists regarding the responsiveness of the CCQ to pulmonary rehabilitation (PR) or the minimal clinically important difference (MCID). The study aims were to assess the responsiveness of the CCQ to PR, to compare the responsiveness of the CCQ to other HRQoL questionnaires and to provide estimates for the MCID.
METHODS: The CCQ, St George's Respiratory Questionnaire (SGRQ), Chronic Respiratory Questionnaire (CRQ) and COPD Assessment Test (CAT) were measured in 261 patients with COPD before and after outpatient PR. Pre to post PR changes and Cohen's effect size were calculated. Changes in CCQ were compared with changes in other HRQoL questionnaires. Using an anchor-based approach and receiver operating characteristic (ROC) curves, the CCQ change cutoffs that identified patients achieving the known MCID for other health status questionnaires with PR were identified.
RESULTS: The CCQ, SGRQ, CRQ and CAT all significantly improved with PR with an effect size of -0.39, -0.33, 0.62 and -0.25, respectively. CCQ change correlated significantly with change in SGRQ, CRQ and CAT (r=0.48, -0.56, 0.54, respectively; all p<0.001). ROC curves consistently identified a CCQ change cutoff of -0.4 as the best discriminating value to identify the MCID for the SGRQ, CRQ and CAT (area under curve: 0.71, 0.75 and 0.77, respectively; all p<0.001).
CONCLUSIONS: The CCQ is responsive to PR with an estimated clinically important improvement of -0.4 points. The CCQ is a practical alternative to more time-consuming measures of HRQoL. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  COPD Pathology; Pulmonary Rehabilitation

Mesh:

Year:  2013        PMID: 24149828     DOI: 10.1136/thoraxjnl-2013-204119

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  32 in total

1.  Individual patient monitoring in daily clinical practice: a critical evaluation of minimal important change.

Authors:  Jos Hendrikx; Jaap Fransen; Wietske Kievit; Piet L C M van Riel
Journal:  Qual Life Res       Date:  2014-09-25       Impact factor: 4.147

2.  The clinical chronic obstructive pulmonary disease questionnaire: cut point for GOLD 2013 classification.

Authors:  Samantha S C Kon; Jane L Canavan; Claire M Nolan; Sarah E Jones; Amy L Clark; Michael I Polkey; William D-C Man
Journal:  Am J Respir Crit Care Med       Date:  2014-01-15       Impact factor: 21.405

3.  Ambulatory Oxygen for Exercise-Induced Desaturation and Dyspnea in Chronic Obstructive Pulmonary Disease (COPD): Systematic Review and Meta-Analysis.

Authors:  Stanley I Ejiofor; Susan Bayliss; Abubacarr Gassamma; Alice M Turner
Journal:  Chronic Obstr Pulm Dis       Date:  2016-01-06

4.  Effect of Two Interventional Strategies on Improving Continuous Positive Airway Pressure Adherence in Existing COPD and Obstructive Sleep Apnea Patients: The O2VERLAP Study.

Authors:  Sergio Martinez; Jamie Sullivan; Cara Pasquale; Bill Clark; Elisha Malanga; Sean Deering; Lin Liu; Carl J Stepnowsky
Journal:  Chronic Obstr Pulm Dis       Date:  2022-07-29

5.  Inter-Day Test-Retest Reproducibility of the CAT, CCQ, HADS and EQ-5D-3L in Patients with Severe and Very Severe COPD.

Authors:  Henrik Hansen; Nina Beyer; Anne Frølich; Nina Godtfredsen; Theresa Bieler
Journal:  Patient Relat Outcome Meas       Date:  2021-06-01

6.  Therapeutic Success of Tiotropium/Olodaterol, Measured Using the Clinical COPD Questionnaire (CCQ), in Routine Clinical Practice: A Multinational Non-Interventional Study.

Authors:  Arschang Valipour; Sergey Avdeev; Adam Barczyk; Valentina Bayer; Zvi Fridlender; Mariela Georgieva; Ondřej Kudela; Alexey Medvedchikov; Ramona Miron; Maria Sanzharovskaya; Virginija Šileikienė; Jurij Šorli; Marc Spielmanns; Zsuzsanna Szalai
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-03-10

7.  Prevention of exacerbations in patients with COPD and vitamin D deficiency through vitamin D supplementation (PRECOVID): a study protocol.

Authors:  Rachida Rafiq; Floor E Aleva; Jasmijn A Schrumpf; Yvonne F Heijdra; Christian Taube; Johannes Ma Daniels; Paul Lips; Pierre M Bet; Pieter S Hiemstra; André Jam van der Ven; Martin den Heijer; Renate T de Jongh
Journal:  BMC Pulm Med       Date:  2015-09-23       Impact factor: 3.317

8.  Impact of Adjuvant Medical Therapies on Surgical Outcomes in Idiopathic Subglottic Stenosis.

Authors:  Matthew R Hoffman; Ankita Patro; Li-Ching Huang; Sheau-Chiann Chen; Lynn D Berry; Alexander Gelbard; David O Francis
Journal:  Laryngoscope       Date:  2021-06-12       Impact factor: 3.325

9.  Health status in patients with coexistent COPD and heart failure: a validation and comparison between the Clinical COPD Questionnaire and the Minnesota Living with Heart Failure Questionnaire.

Authors:  Farida F Berkhof; Leola Metzemaekers; Steven M Uil; Huib A M Kerstjens; Jan W K van den Berg
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-09-22

10.  The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference.

Authors:  Claire M Nolan; Louise Longworth; Joanne Lord; Jane L Canavan; Sarah E Jones; Samantha S C Kon; William D-C Man
Journal:  Thorax       Date:  2016-03-30       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.